All these exceptional leaders are creating new opportunities for growth by combining a human understanding of technology and data with the drive to make healthcare improvements more accessible.
With the theme ‘Making opportunities’, the report showcases women at the forefront of the UK’s flourishing life sciences sector including:
Pioneering scientists developing revolutionary healthcare products
Financial experts shaping the sector through diverse investments
Motivating and inclusive collaborators who get the job done
Innovators whose inventions are making an impact on patients’ lives
Infrastructure specialists supporting innovation at scale, from concept to execution
This year’s Movers and Shakers also features insights from five alumni from previous reports who share their vision for the opportunities that lie ahead as we move through the pandemic and beyond.
Hayaatun Sillem, CEO of the Royal Academy of Engineering, writes in the Foreword: “These extraordinary times have brought into sharp focus the vital role of innovation in addressing threats to health and wellbeing and creating new opportunities to deliver societal benefit. The Movers and Shakers featured in this report are outstanding exemplars of diverse, innovative and inclusive leaders who are harnessing the potential of engineering, technology and science to create new opportunities for progress in the life sciences and healthcare.”
BioBeat founder Miranda Weston-Smith writes: “2021 has been a vindication of the power of science to make a difference to human health and the UK life sciences community continues to lead the way. Ranging from academia to industry and public sector to private equity, the leaders featured in this year’s report are shaping the healthcare landscape of the future. Congratulations to everyone featured and many thanks to the nominators and expert reviewers who provide their time and insights to make this such a valuable resource.”
The Movers and Shakers in BioBusiness report is released in advance of the BioBeat21 Summit: Transforming medicine development through digital innovation on Tuesday 9th November (14.00 – 16.30 GMT).
Livestreamed from AstraZeneca’s global R&D Centre in Cambridge, UK, the Summit will bring together scientists, entrepreneurs, innovators and investors to explore how to optimise outcomes for patients through digital innovation in clinical trials and beyond.
Following a keynote talk from Cristina Durán, Chief Digital Health Officer R&D, AstraZeneca, on innovating to improve patient experience and outcomes in clinical trials, two panels will discuss how we can sustain the pace of innovation through digital health in clinical trials, how entrepreneurs can demonstrate the value of digital innovation, and what investors look for in this fast-growing clinical area.
The BioBeat21 Summit will be co-hosted by Miranda Weston-Smith and Catherine Priestley, Head of BioPharmaceuticals R&D Communications at AstraZeneca.
The full Movers & Shakers in BioBusiness 2021 report is available to download here
Free registration is now open for the BioBeat21 Summit: Transforming medicine development through digital innovation here
About BioBeat’s Movers and Shakers in BioBusiness report
The women highlighted in this year’s report have been nominated by the biobusiness community, together with Miranda’s research and insights. The selection was reviewed by a distinguished panel of business leaders, entrepreneurs and pioneering scientists working in the UK life sciences sector.
About the BioBeat21 Summit
Tuesday 9th November 2021, 14:00-16:30 GMT
Livestreamed from the AstraZeneca R&D Centre, Cambridge
*Please note that the event will only be livestreamed and will not be recorded*
View the full programme and register to attend for free here
About BioBeat 2021 partners
The Movers and Shakers in BioBusiness 2021 report and the BioBeat21 Summit are produced with the support of:
Appleyard Lees
AstraZeneca
Covington
The Entrepreneurship Centre at Cambridge Judge Business School
Innovation forum
One Nucleus